1. Home
  2. DNLI vs WSFS Comparison

DNLI vs WSFS Comparison

Compare DNLI & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • WSFS
  • Stock Information
  • Founded
  • DNLI 2013
  • WSFS 1980
  • Country
  • DNLI United States
  • WSFS United States
  • Employees
  • DNLI N/A
  • WSFS N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • WSFS Major Banks
  • Sector
  • DNLI Health Care
  • WSFS Finance
  • Exchange
  • DNLI Nasdaq
  • WSFS Nasdaq
  • Market Cap
  • DNLI 3.3B
  • WSFS 3.1B
  • IPO Year
  • DNLI 2017
  • WSFS N/A
  • Fundamental
  • Price
  • DNLI $21.93
  • WSFS $54.12
  • Analyst Decision
  • DNLI Strong Buy
  • WSFS Buy
  • Analyst Count
  • DNLI 13
  • WSFS 4
  • Target Price
  • DNLI $38.91
  • WSFS $59.00
  • AVG Volume (30 Days)
  • DNLI 1.1M
  • WSFS 301.9K
  • Earning Date
  • DNLI 02-25-2025
  • WSFS 01-27-2025
  • Dividend Yield
  • DNLI N/A
  • WSFS 1.11%
  • EPS Growth
  • DNLI N/A
  • WSFS N/A
  • EPS
  • DNLI N/A
  • WSFS 4.39
  • Revenue
  • DNLI N/A
  • WSFS $971,986,000.00
  • Revenue This Year
  • DNLI N/A
  • WSFS N/A
  • Revenue Next Year
  • DNLI $651.24
  • WSFS N/A
  • P/E Ratio
  • DNLI N/A
  • WSFS $12.33
  • Revenue Growth
  • DNLI 204.74
  • WSFS 4.32
  • 52 Week Low
  • DNLI $14.56
  • WSFS $40.20
  • 52 Week High
  • DNLI $33.33
  • WSFS $62.75
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 51.28
  • WSFS 50.18
  • Support Level
  • DNLI $18.52
  • WSFS $52.98
  • Resistance Level
  • DNLI $22.37
  • WSFS $55.36
  • Average True Range (ATR)
  • DNLI 1.31
  • WSFS 1.48
  • MACD
  • DNLI 0.31
  • WSFS 0.24
  • Stochastic Oscillator
  • DNLI 88.57
  • WSFS 77.37

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About WSFS WSFS Financial Corporation

WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.

Share on Social Networks: